Design of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis.

Yang H, Li J, Patel SK, Palmer KE, Devlin B, Rohan LC

Open source

DOI
10.3390/pharmaceutics11040184
Published
2019 Apr 16
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics11040184,
  title = {Design of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis.},
  author = {Yang H and Li J and Patel SK and Palmer KE and Devlin B and Rohan LC},
  year = {2019},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics11040184},
  url = {https://doi.org/10.3390/pharmaceutics11040184}
}

RIS

TY  - JOUR
TI  - Design of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis.
AU  - Yang H
AU  - Li J
AU  - Patel SK
AU  - Palmer KE
AU  - Devlin B
AU  - Rohan LC
PY  - 2019
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics11040184
UR  - https://doi.org/10.3390/pharmaceutics11040184
ER  - 

APA

H, Y., J, L., SK, P., KE, P., B, D., & LC, R. (2019). Design of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics11040184

Source records